(Q39799090)

14 September 2017

title

The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939. (English)

1 reference

14 September 2017

0 references

1 reference

1 reference

Zhi-Hua Liu

1

1 reference

14 September 2017

Yan-Ping He

series ordinal

2

1 reference

14 September 2017

Huanlong Qin

series ordinal

3

1 reference

14 September 2017

publication date

13 September 2009

1 reference

Molecular Biology Reports

14 September 2017

published in

1 reference

14 September 2017

volume

37

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

2693-2701

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-009-9801-2

14 September 2017

exact match

0 references

cites work

Intrahepatic cholangiocarcinoma associated with intrahepatic duct stones.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11033-009-9801-2

Changing strategies in diagnosis and management of hilar cholangiocarcinoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11033-009-9801-2

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11033-009-9801-2

Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma

21 January 2018

1 reference

12 December 2020

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

1 reference

12 December 2020

Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport

1 reference

12 December 2020

Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells

1 reference

12 December 2020

Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma.

1 reference

12 December 2020

Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline

1 reference

12 December 2020

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

12 December 2020

ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

1 reference

12 December 2020

Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study

1 reference

12 December 2020

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

1 reference

12 December 2020

Magnetic cell separation using nano-sized bacterial magnetic particles with reconstructed magnetosome membrane

1 reference

12 December 2020

1 reference

12 December 2020

Mechanisms of tamoxifen-induced apoptosis

1 reference

12 December 2020

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

1 reference

12 December 2020

The multiple applications of tamoxifen: an example pointing to SERM modulation being the aspirin of the 21st century.

1 reference

12 December 2020

Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery

1 reference

12 December 2020

A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma

1 reference

12 December 2020

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).

1 reference

12 December 2020

Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women

1 reference

12 December 2020

Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor

1 reference

12 December 2020

Biliary tract cancers.

1 reference

12 December 2020

Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage

1 reference

12 December 2020

Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression

1 reference

12 December 2020

Tamoxifen: teaching an old drug new tricks?

1 reference

12 December 2020

Treatment strategy for patients with middle and lower third bile duct cancer

1 reference

12 December 2020

Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy

1 reference

12 December 2020

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

1 reference

12 December 2020

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels.

1 reference

12 December 2020

The epidemiology of cholangiocarcinoma

1 reference

12 December 2020

Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene

1 reference

12 December 2020

10.1007/S11033-009-9801-2

Identifiers

DOI

1 reference

14 September 2017

1 reference